Clinical Trials Logo

Clinical Trial Summary

Using a multi-echo gradient echo sequence to calculate R2* and quantitative susceptibility maps and well as susceptibility-weighted imaging post processing the investigators hypothesize that the investigators would be able to distinguish between pseudoprogression and true progression with the use of an easily implementable sequence on clinical MRI scanners.


Clinical Trial Description

Post-treatment radiographic imaging change (PTRIC) is seen in approximately 50% of patients who are treated for brain neoplasms using chemotherapy and radiotherapy. PTRIC can be attributed to true disease progression or a form of benign radiographic enhancement, known in literature as pseudoprogression. Of these patients, 50% of them have benign radiographic enhancement that is usually spontaneously resolved and required no intervention. The other 50% require immediate medical intervention, or more aggressive treatment for true progression. Currently standard medical practise is to administer a prophylactic treatment of chemotherapy to all patients with PTRIC with a follow up scan 3-6 months after initial PTRIC diagnosis, leading to up to 50% of patients receiving an unneeded dose of chemotherapy. The investigators hope to take advantage of the differentiation in tissue types and vascularization between true progression tumour and pseudoprogression to be able to identify patients who would not need to be administered a prophylactic dose of chemotherapy. ;


Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT02212964
Study type Observational
Source Centre for Functional and Metabolic Mapping
Contact
Status Completed
Phase N/A
Start date July 2014
Completion date March 2016

See also
  Status Clinical Trial Phase
Recruiting NCT02152722 - Breath Test for Biomarkers in Humans Receiving Total Body Irradiation N/A
Completed NCT00760409 - Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI N/A
Withdrawn NCT00745641 - Abdominal Computed Tomography and the Blood Reactive Oxygen Species Level N/A
Active, not recruiting NCT02725840 - Breast Cancer Lung Late Effects
Completed NCT02478255 - Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment Phase 2
Withdrawn NCT00815230 - Effect of Cardiac Computed Tomography Angiography on the Blood Reactive Oxygen Species Level N/A
Completed NCT01334931 - Use of Large Field of View During Image Acquisition for Coronary Angiography Phase 3